TDC
TRIL

Thompson Davis & Co’s Trillium Therapeutics Inc. TRIL Stock Holding History

Thompson Davis & Co’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,000
Closed -$45K – 1309
2014
Q4 		$45K Buy
+5,000
New +$45K 0.05% 303